Fly News Breaks for February 10, 2020
Feb 10, 2020 | 09:43 EDT
As previously reported, Stephens analyst Mark Connelly resumed coverage of Neogen at Overweight with an $88 price target, up from the firm's previous Equal Weight rating and $58 price target under the prior analyst. Neogen "tends to be lumped together with Medical Devices," but they make up only a small percent of its revenues, contends Connelly, who sees the company being positioned to benefit from several emerging food and ag tech trends as consumers turn away from traditional brands in favor of "clean labels" and healthier alternatives.
News For NEOG From the Last 2 Days
There are no results for your query NEOG